The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma
{{output}}
Erlotinib, a tyrosine kinase inhibitor, has been shown to improve the survival of patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer. Sarcopenia is a status with increasing importance in lung cancer, and it may predict a p... ...
